Publication: ATRACTIB: A phase II trial of first-line (1L) atezolizumab (A) in combination with paclitaxel (P) and bevacizumab (B) in metastatic triple-negative breast cancer (mTNBC)
No Thumbnail Available
Identifiers
Date
2022-05-05
Authors
Cortes Salgado, A.
Perez Garcia, J. M.
Cortez Castedo, S. P.
Gion Cortes, M.
Morales Murillo, S.
Blancas Lopez-Barajas, I.
Blanch, S.
Calvo Plaza, I.
Diaz Fernandez, N.
Marme, F.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
